Why the study?
Does the HeartMate II continuous-flow left ventricular assist device improve renal and hepatic function in advanced heart failure patients bridged to transplantation?
Population
Advanced heart failure patients who are being bridged to transplantation
Design
Cohort
Follow-up
6 months
Authors
Loading...
May support end-organ recovery with HeartMate II in bridge-to-transplant; leaves open need for randomized confirmation of long-term pulsatility effects.
Does the HeartMate II continuous-flow left ventricular assist device improve renal and hepatic function in advanced heart failure patients bridged to transplantation?
Continuous-flow LVAD support with HeartMate II improves renal and hepatic function in advanced heart failure patients awaiting transplant over 6 months.
Russell et al. (2009) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: